PJ, December 2017, Vol 299, No 7908

NHS England publishes new prescribing guidance in bid to save millions of pounds

NHS England has published national guidance on a range of medicines which should no longer be routinely prescribed in primary care…

GPhC members visit UCLan School of Pharmacy

Members of the General Pharmaceutical Council have visited students at the University of Central Lancashire’s School of Pharmacy in Preston…

Pharmacy Research UK awards more than £80k in funding

Six pharmacy researchers will share more than £80,000 of funding awarded by Pharmacy Research UK…

Scarlet fever in England reaches highest level in 50 years

England is experiencing an unprecedented rise in scarlet fever with the highest incidence for nearly 50 years, according to a study published in The Lancet Infectious Diseases.…

NICE asks Merck to submit Cancer Drugs Fund proposal for immunotherapy drug

The National Institute for Health and Care Excellence has asked pharmaceutical company, Merck, to submit a Cancer Drugs Fund proposal for its immunotherapy drug avelumab (Bavencio; Merck)…

Pre-reg application system rated as poor by 53% pharmacy students

Pharmacy students were disappointed with the new national application system to find a preregistration training place in England this year, according to the results of a survey.…

NHS Digital announces new cyber attack messaging system

NHS Digital has established a new system to send cyber security updates across the NHS.…

Sildenafil to be reclassified to P medicine

Sildenafil is to be formally reclassified from a prescription only medicine to a pharmacy medicine, the Medicines and Healthcare products Regulatory Agency has announced.…

Pharmacy minister confirms just £2m of Pharmacy Integration Fund spend

The pharmacy minster Steve Brine has told MPs that he can only confirm that £2m of the promised £42m of Pharmacy Integration Fund (PhiF) funding for 2016-18 has been spent.…

Government launches consultation on reclassification of gabapentinoids

The government has launched its consultation on the reclassification of pregabalin and gabapentin.…